If you want different results, do not do the same things

Albert Einstein

Nanokide Therapeutics is a biotechnology company focused on the development of novel antimetastatic solutions based on the combination of nanotechnology and microRNA and mRNA.

Our nanosystems is a flexible, non-toxic and easy to produce formulation that combined with microRNA and mRNA sequences offer a perfect platform for anticancer drugs development.

Maitane Duarte

CSO and Founder

MD Biology / Researcher

Iker Badiola

CEO and Founder

PhD in Biology / Assistant professor in UPV/EHU

Majid Khatib


PhD in Biology/ INSERM

The core of our technology is the combination of a flexible nanosystem with microRNA and mRNA therapy against cancer.
The nanosystem developed by Nanokide is based on sorbitan ester.

Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver

Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems

Xanthan gum-functionalised span nanoparticles for gene targeting to endothelial cells


NIH granted Nanokide

The NCL has selected our technology Span-based nanoparticles loaded with miR-20a for the preclinical development program

Read More

Toribio Echevarria Awards

Nanokide awarded as finalist in the Business Ideas/Projects section of the Toribio Echevarria 2022 awards.

Read More

Cantábrico Excelente Awards

Nanokide Therapeutics awarded in the category of best R+D+i company in the VI edition of the Cantabrian Excellent Awards.

Read More

"Our nanoparticle blocks tumor growth"

Interview in the newspaper Berria

Read More

Nanokide in B-Venture 2022

Nanokid Therapeutics participated in B-Venture 2022 in Bilbao from 18th to 19th of October

Read More

Finalist Toribio Echevarria Awards 2022

Awarded Cantábrico de Excelencia Award 2022


  • Ed. Rectorado – Planta baja Campus de Bizkaia. Sarriena s/n. 48940 Leioa

Videos, images and gifs made by Rosario García Hernández